# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-050431
Filing Date
2026-04-28
Accepted
2026-04-28 16:45:59
Documents
17
Period of Report
2026-06-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ganx-20260624xdef14a.htm iXBRL | DEF 14A | 570343
2 | GRAPHIC | ganx-20260624xdef14a_a001.jpg | GRAPHIC | 7845
3 | GRAPHIC | ganx-20260624xdef14a_bg001.jpg | GRAPHIC | 187939
4 | GRAPHIC | ganx-20260624xdef14a_bg002.jpg | GRAPHIC | 90006
| Complete submission text file | 0001104659-26-050431.txt |  | 1724989

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | ganx-20260624.xsd | EX-101.SCH | 4020
6 | EX-101.DEF | ganx-20260624_def.xml | EX-101.DEF | 3554
7 | EX-101.LAB | ganx-20260624_lab.xml | EX-101.LAB | 4689
8 | EX-101.PRE | ganx-20260624_pre.xml | EX-101.PRE | 4163
20 | EXTRACTED XBRL INSTANCE DOCUMENT | ganx-20260624xdef14a_htm.xml | XML | 94029

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40237 | Film No.: 26908737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)